Infection control experience in a cooperative care center for transplant patients

Infect Control Hosp Epidemiol. 2008 May;29(5):424-9. doi: 10.1086/587188.

Abstract

Objective: To characterize infection control experience during a 6.5-year period in a cooperative care center for transplant patients.

Design: Descriptive analysis.

Setting: A cooperative care center for transplanted patients, in which patients and care partners are housed in a homelike environment, and care partners assume responsibility for patient care duties.

Patients: Nine hundred ninety one transplant patients.

Methods: Infection control definitions from the Centers for Disease Control and Prevention were used to ascertain infection rates. Environmental cultures were used to detect methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococcus (VRE), Clostridium difficile, and fungi during the first 18 months. Surveillance cultures were performed for a subset of patients and care partners.

Results: From June 1999 through December 2005, there were 19,365 patient-days observed. The most common healthcare-associated infection encountered was intravascular catheter-related bloodstream infection, with infection rates of 5.74 and 4.94 cases per 1,000 patient-days for hematopoietic stem cell transplant (HSCT) and solid organ transplant (SOT) patients, respectively. C. difficile-associated diarrhea was observed more frequently in HSCT patients than in SOT patients (3.97 vs 0.57 cases per 1,000 patient-days; P < .0001). There was no evidence of environmental contamination with MRSA, VRE, or C. difficile. Acquisition of MRSA was not observed. Acquisition of VRE was documented.

Conclusion: This study documented that cooperative care was associated with some risk of healthcare-associated infection, most notably intravascular catheter-associated bloodstream infection and C. difficile-associated diarrhea, it appears the incidences of these infections were roughly commensurate with those in other care settings.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteremia / epidemiology*
  • Bacteremia / microbiology
  • Bacteremia / prevention & control
  • Catheterization, Central Venous / adverse effects*
  • Clostridioides difficile / isolation & purification
  • Cooperative Behavior*
  • Cross Infection / epidemiology*
  • Cross Infection / microbiology
  • Cross Infection / prevention & control
  • Delivery of Health Care / methods*
  • Diarrhea / epidemiology
  • Diarrhea / microbiology
  • Diarrhea / prevention & control
  • Gram-Negative Bacteria / isolation & purification
  • Gram-Positive Cocci / isolation & purification
  • Hematopoietic Stem Cell Transplantation* / adverse effects
  • Humans
  • Incidence
  • Infection Control / methods*
  • Organ Transplantation* / adverse effects